|
| 37832946 | Comparative Pathogenesis of Severe Acute Respiratory Syndrome Coronaviruses. | Annu Rev Pathol | 2024 |
| 36257333 | Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. | Nat Med | 2023 |
| 37808679 | Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera. | bioRxiv | 2023 |
| 37561789 | Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface. | PLoS Pathog | 2023 |
| 37555660 | SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models. | J Virol | 2023 |
| 37623322 | SARS-CoV-2 ORF8 accessory protein is a virulence factor. | mBio | 2023 |
| 37949319 | Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry. | Antiviral Res | 2023 |
| 37647851 | Antigenic evolution of SARS coronavirus 2. | Curr Opin Virol | 2023 |
| 37673225 | The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses. | Clin Immunol | 2023 |
| 37154754 | Correction for Mols et al., "Intestinal Tropism of a Betacoronavirus (<i>Merbecovirus</i>) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host". | J Virol | 2023 |
| 37012235 | Mpox virus infects and injures human kidney organoids, but responding to antiviral treatment. | Cell Discov | 2023 |
| 37072183 | The pro-inflammatory response to influenza A virus infection is fueled by endothelial cells. | Life Sci Alliance | 2023 |
| 37097842 | ICTV Virus Taxonomy Profile: <i>Coronaviridae</i> 2023. | J Gen Virol | 2023 |
| 37359531 | Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system <i>Thermothelomyces heterothallica</i> C1. | Front Immunol | 2023 |
| 36857443 | Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome-Coronavirus Spike Protein. | J Infect Dis | 2023 |
| 36856426 | Intestinal Tropism of a Betacoronavirus (<i>Merbecovirus</i>) in Nathusius's Pipistrelle Bat (<i>Pipistrellus nathusii</i>), Its Natural Host. | J Virol | 2023 |
| 36680252 | Reduced Seasonal Coronavirus Antibody Responses in Children Following COVID-19 Mitigation Measures, The Netherlands. | Viruses | 2023 |
| 36895554 | Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants. | Front Immunol | 2023 |
| 36823022 | Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C Strain. | Emerg Infect Dis | 2023 |
| 36657480 | Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1. | Lancet Microbe | 2023 |
| 34839786 | Experimental and field investigations of exposure, replication and transmission of SARS-CoV-2 in pigs in the Netherlands. | Emerg Microbes Infect | 2022 |
| 35739576 | Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas. | One Health Outlook | 2022 |
| 35737747 | Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct. | Sci Immunol | 2022 |
| 35471062 | An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern. | Sci Immunol | 2022 |
| 35725735 | SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters. | Nat Commun | 2022 |
| 35637337 | An early warning system for emerging SARS-CoV-2 variants. | Nat Med | 2022 |
| 35396474 | Methods for fighting emerging pathogens. | Nat Methods | 2022 |
| 35853863 | Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome. | Nat Commun | 2022 |
| 35695453 | Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern. | mBio | 2022 |
| 35787236 | Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters. | Emerg Microbes Infect | 2022 |
| 35779493 | Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids. | EBioMedicine | 2022 |
| 35354968 | SARS-CoV-2 pathogenesis. | Nat Rev Microbiol | 2022 |
| 35255100 | Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns. | PLoS Pathog | 2022 |
| 35279247 | Spreading of SARS-CoV-2 from hamsters to humans. | Lancet | 2022 |
| 35001773 | Middle East respiratory syndrome coronavirus infection in camelids. | Vet Pathol | 2022 |
| 35058606 | SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination. | Cell Res | 2022 |
| 35113647 | Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients. | Sci Immunol | 2022 |
| 34767118 | Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19. | J Clin Immunol | 2022 |
| 33356979 | Susceptibility of rabbits to SARS-CoV-2. | Emerg Microbes Infect | 2021 |
| 33597220 | Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. | Science | 2021 |
| 33731724 | A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies. | Nat Commun | 2021 |
| 33835028 | Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation. | Elife | 2021 |
| 33772778 | A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice. | Eur J Immunol | 2021 |
| 33577765 | Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. | Cell | 2021 |
| 35164568 | Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets. | mBio | 2021 |
| 34736782 | Zoonoses Anticipation and Preparedness Initiative, stakeholders conference, February 4 & 5, 2021. | Biologicals | 2021 |
| 34499051 | Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19. | J Clin Invest | 2021 |
| 34762662 | Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens. | PLoS One | 2021 |
| 34611328 | Author Correction: The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology. | Nat Med | 2021 |
| 34458548 | Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test. | One Health | 2021 |